USPTO serial 79346219
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey H. Greger
Jeffrey H. Greger STUDEBAKER BRACKETT PLLC8255 Greensboro DriveSuite 300Tysons, VA 22102| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products and preparations for prevention, treatment and immune therapy and combinations of prevention, treatment and immune therapy of infectious diseases and allergic diseases, as well as pharmaceutical products and preparations against cancer; vaccines; and medicines for human use for prevention, treatment and immune therapy and combinations of prevention, treatment and immune therapy of infectious diseases, allergic diseases and cancer; bacterial and viral vaccines, synthetic, recombinant, peptide, protein, RNA-, DNA- and therapeutic vaccines; all the aforementioned products not for the ocular, periocular and vision field; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibodies; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibody drug conjugates | ACTIVE | — |
| 010 | Apparatus and containers for the administration of vaccines and medicines, namely cups for dispensing medicine, injection needles for the administration of vaccines and medicines, injection instruments without needles for the administration of vaccines and medicines, nose sprayers for medical purposes and spray syringes for medical purposes; all the aforementioned products not for the ocular, periocular and vision field; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibodies; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibody drug conjugates | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 21, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 21, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 21, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 26, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 29, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 29, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 28, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 28, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 28, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 12, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 12, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 12, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 23, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 23, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 23, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 4, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 26, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 26, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 26, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 17, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 26, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 26, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 8, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 2, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 29, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 28, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |